Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $135.7 million.

  • National Research's Liabilities and Shareholders Equity rose 297.5% to $135.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $544.8 million, marking a year-over-year increase of 1023.28%. This contributed to the annual value of $132.5 million for FY2024, which is 825.08% up from last year.
  • As of Q3 2025, National Research's Liabilities and Shareholders Equity stood at $135.7 million, which was up 297.5% from $141.4 million recorded in Q2 2025.
  • In the past 5 years, National Research's Liabilities and Shareholders Equity ranged from a high of $157.5 million in Q4 2021 and a low of $119.1 million during Q2 2024
  • For the 5-year period, National Research's Liabilities and Shareholders Equity averaged around $136.5 million, with its median value being $135.0 million (2022).
  • As far as peak fluctuations go, National Research's Liabilities and Shareholders Equity surged by 3002.89% in 2021, and later crashed by 1718.87% in 2022.
  • Over the past 5 years, National Research's Liabilities and Shareholders Equity (Quarter) stood at $157.5 million in 2021, then decreased by 17.19% to $130.5 million in 2022, then decreased by 6.15% to $122.4 million in 2023, then grew by 8.25% to $132.5 million in 2024, then rose by 2.4% to $135.7 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $135.7 million for Q3 2025, versus $141.4 million for Q2 2025 and $135.2 million for Q1 2025.